title: CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism?
authors.forename: Matthew
authors.initials: M
authors.lastname: Macaluso
authors.forename: Sheldon H
authors.initials: SH
authors.lastname: Preskorn
mesh_terms: D000928:Antidepressive Agents / Q000378:metabolism* / Q000627:therapeutic use; D002384:Catalysis / Q000187:drug effects; D003511:Cyclohexanols / Q000378:metabolism* / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D009661:Nortriptyline / Q000378:metabolism* / Q000627:therapeutic use; D013379:Substrate Specificity / Q000187:drug effects; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D000928:Antidepressive Agents; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D009661:Nortriptyline; D019389:Cytochrome P-450 CYP2D6